Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yasuhiro Yuasa

Multicenter Phase II Study of Trastuzumab Plus S-1 Alone in Elderly Patients With HER2-positive Advanced Gastric Cancer (JACCRO GC-06)

Gastric Cancer

English

Related publications

A Phase I/Ii Study of Poziotinib Combined With Paclitaxel and Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer

English

O1-20-2a Randomized Phase II Study to Assess Trastuzumab Beyond Progression in HER2-positive Advanced Gastric Cancer: WJOG7112G

English

Multicenter Phase II Study of Docetaxel Plus Oxaliplatin Combination Chemotherapy in Patients With Advanced Gastric Cancer: Daegu Gyeongbuk Oncology Group

British Journal of Cancer

Cancer Research

Oncology

2008

English

Clinical Significance of Intratumoral HER2 Heterogeneity on Trastuzumab Efficacy Using Endoscopic Biopsy Specimens in Patients With Advanced HER2 Positive Gastric Cancer

English

Relationship Between Tumor Biomarkers and Efficacy in MARIANNE, a Phase III Study of Trastuzumab Emtansine ± Pertuzumab Versus Trastuzumab Plus Taxane in HER2-positive Advanced Breast Cancer

English

P3-013a Phase 1b Study of S-1 Combined With Trastuzumab Emtansine (T-Dm1) for HER2 Positive Metastatic Breast Cancer

English

Phase I/Ii Study of S-1 Combined With Paclitaxel in Patients With Unresectable and/or Recurrent Advanced Gastric Cancer

British Journal of Cancer

Cancer Research

Oncology

2006

English

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

New England Journal of Medicine

Medicine

2005

English

P1.01-32 a Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients With Interstitial Lung Disease

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yasuhiro Yuasa

Multicenter Phase II Study of Trastuzumab Plus S-1 Alone in Elderly Patients With HER2-positive Advanced Gastric Cancer (JACCRO GC-06)

Related publications

A Phase I/Ii Study of Poziotinib Combined With Paclitaxel and Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer

O1-20-2a Randomized Phase II Study to Assess Trastuzumab Beyond Progression in HER2-positive Advanced Gastric Cancer: WJOG7112G

Multicenter Phase II Study of Docetaxel Plus Oxaliplatin Combination Chemotherapy in Patients With Advanced Gastric Cancer: Daegu Gyeongbuk Oncology Group

Clinical Significance of Intratumoral HER2 Heterogeneity on Trastuzumab Efficacy Using Endoscopic Biopsy Specimens in Patients With Advanced HER2 Positive Gastric Cancer

Relationship Between Tumor Biomarkers and Efficacy in MARIANNE, a Phase III Study of Trastuzumab Emtansine ± Pertuzumab Versus Trastuzumab Plus Taxane in HER2-positive Advanced Breast Cancer

P3-013a Phase 1b Study of S-1 Combined With Trastuzumab Emtansine (T-Dm1) for HER2 Positive Metastatic Breast Cancer

Phase I/Ii Study of S-1 Combined With Paclitaxel in Patients With Unresectable and/or Recurrent Advanced Gastric Cancer

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

P1.01-32 a Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients With Interstitial Lung Disease